rs133376

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBA1

The ENST00000898674.1(NAGA):​c.-70+183G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.37 in 166,156 control chromosomes in the GnomAD database, including 13,464 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.36 ( 11709 hom., cov: 34)
Exomes 𝑓: 0.49 ( 1755 hom. )

Consequence

NAGA
ENST00000898674.1 intron

Scores

3

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.190

Publications

20 publications found
Variant links:
Genes affected
NAGA (HGNC:7631): (alpha-N-acetylgalactosaminidase) NAGA encodes the lysosomal enzyme alpha-N-acetylgalactosaminidase, which cleaves alpha-N-acetylgalactosaminyl moieties from glycoconjugates. Mutations in NAGA have been identified as the cause of Schindler disease types I and II (type II also known as Kanzaki disease). [provided by RefSeq, Jul 2008]
NAGA Gene-Disease associations (from GenCC):
  • alpha-N-acetylgalactosaminidase deficiency
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • alpha-N-acetylgalactosaminidase deficiency type 2
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Genomics England PanelApp, Orphanet
  • alpha-N-acetylgalactosaminidase deficiency type 1
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet
  • alpha-N-acetylgalactosaminidase deficiency type 3
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000898674.1, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.41).
BP6
Variant 22-42070901-C-T is Benign according to our data. Variant chr22-42070901-C-T is described in ClinVar as Benign. ClinVar VariationId is 684292.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.48 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000898674.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NAGA
NM_000262.3
MANE Select
c.-604G>A
upstream_gene
N/ANP_000253.1P17050
NAGA
NM_001362848.1
c.-215G>A
upstream_gene
N/ANP_001349777.1P17050
NAGA
NM_001362850.1
c.-208G>A
upstream_gene
N/ANP_001349779.1P17050

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NAGA
ENST00000898674.1
c.-70+183G>A
intron
N/AENSP00000568733.1
NAGA
ENST00000958241.1
c.-77+183G>A
intron
N/AENSP00000628300.1
NAGA
ENST00000396398.8
TSL:1 MANE Select
c.-604G>A
upstream_gene
N/AENSP00000379680.3P17050

Frequencies

GnomAD3 genomes
AF:
0.359
AC:
54592
AN:
152072
Hom.:
11697
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.117
Gnomad AMI
AF:
0.489
Gnomad AMR
AF:
0.489
Gnomad ASJ
AF:
0.361
Gnomad EAS
AF:
0.324
Gnomad SAS
AF:
0.452
Gnomad FIN
AF:
0.503
Gnomad MID
AF:
0.354
Gnomad NFE
AF:
0.448
Gnomad OTH
AF:
0.383
GnomAD4 exome
AF:
0.491
AC:
6860
AN:
13966
Hom.:
1755
AF XY:
0.492
AC XY:
3740
AN XY:
7602
show subpopulations
African (AFR)
AF:
0.169
AC:
41
AN:
242
American (AMR)
AF:
0.541
AC:
1363
AN:
2518
Ashkenazi Jewish (ASJ)
AF:
0.380
AC:
38
AN:
100
East Asian (EAS)
AF:
0.381
AC:
282
AN:
740
South Asian (SAS)
AF:
0.498
AC:
1315
AN:
2640
European-Finnish (FIN)
AF:
0.590
AC:
131
AN:
222
Middle Eastern (MID)
AF:
0.536
AC:
15
AN:
28
European-Non Finnish (NFE)
AF:
0.492
AC:
3404
AN:
6918
Other (OTH)
AF:
0.486
AC:
271
AN:
558
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.524
Heterozygous variant carriers
0
165
329
494
658
823
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
90
180
270
360
450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.359
AC:
54610
AN:
152190
Hom.:
11709
Cov.:
34
AF XY:
0.365
AC XY:
27183
AN XY:
74398
show subpopulations
African (AFR)
AF:
0.116
AC:
4838
AN:
41544
American (AMR)
AF:
0.489
AC:
7479
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.361
AC:
1255
AN:
3472
East Asian (EAS)
AF:
0.325
AC:
1677
AN:
5160
South Asian (SAS)
AF:
0.453
AC:
2184
AN:
4824
European-Finnish (FIN)
AF:
0.503
AC:
5324
AN:
10586
Middle Eastern (MID)
AF:
0.342
AC:
100
AN:
292
European-Non Finnish (NFE)
AF:
0.448
AC:
30483
AN:
67984
Other (OTH)
AF:
0.389
AC:
824
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
1664
3329
4993
6658
8322
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
518
1036
1554
2072
2590
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.395
Hom.:
3161
Bravo
AF:
0.350
Asia WGS
AF:
0.414
AC:
1438
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.41
CADD
Benign
15
DANN
Benign
0.92
PhyloP100
-0.19
PromoterAI
-0.25
Neutral
Mutation Taster
=100/0
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs133376;
hg19: chr22-42466905;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.